Clinical Trial Update: Albumin-bound Paclitaxel Combined With Cisplatin Versus Docetaxel Combined With Cisplatin Induced Chemotherapy in Advanced Head and Neck Squamous Tummor [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing albumin-bound paclitaxel plus cisplatin versus docetaxel plus cisplatin in advanced head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 4 | Status: UNKNOWN